- Form 8 Filing
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
PALM BEACH GARDENS, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. ("Molekule" or the "Company") (NASDAQ:MKUL), a leading air purification technology company, today announced new laboratory results that highlight the power of the Company's proprietary photoelectrochemical oxidation ("PECO") technology and its ability to destroy what conventional filters leave behind. Three new studies were completed, including one from Florida International University, that demonstrate that Molekule's PECO technology can safely destroy a vast range of indoor air pollutants. PECO technology for air purification reacts with ultraviolet light to oxidize pollutants, including viruses, bacteria
PALM BEACH GARDENS, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. ("Molekule" or the "Company") (NASDAQ:MKUL), a leading air purification technology company, today reported financial results for the three months ("Q2 2023") ended June 30, 2023. Second Quarter 2023 Financial and Operational Highlights(Unless otherwise stated, comparisons are made between Q2 2023 and Q2 2022 results) Revenues were $13.2 million, an increase of 58% as compared to the first quarter of 2023.Gross profit was $4.5 million, or $5.7 million on an adjusted basis to exclude $1.2 million of costs resulting from a step up in inventory value related to purchase accounting. Gross profit margin giving eff
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer. Harris joins Owlet at a pivotal time in its business – one month after receiving clearance from the U.S. Food and Drug Administration ("FDA") of BabySat™, the first medical pulse-oximetry device featuring Owlet's advanced, wire-free sock design. With a proven track record in leading go-to-market strategies for some of the world's top brands including Microsoft, Roku, GoPro, and Jawbone, Harris brings more than 30 years of experience to Owlet. Harris scaled GoPro from $19 Million to more than $1.
Q1 2023 Revenues of $8.3 Million Exceed Guidance Announces Q2 2023 Revenue Guidance of Approximately $12 Million Up Approximately 45% with Substantially Improved EBITDA Due to Significant Increases in Gross Profit and Operating Leverage, All as Compared to Q1 2023 Remains on Target to Achieve Full Year Fiscal 2023 Revenue Guidance of Between $60-$70 Million PALM BEACH GARDENS, Fla., May 16, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. ("Molekule" or the "Company") (NASDAQ:MKUL), an emerging leader in air purification technology solutions, systems for healthcare and commercial smart building applications, and individual consumer protection, today rep
Education industry sales reach nearly $4M Installed base hits over 11,000 air purifiers in schools, including some of the largest school districts in the U.S., eliminating SARS-CoV-2, RSV, H1N1 Flu Virus, bacteria and allergens from the airThousands of classrooms and facilities on numerous campuses are now experiencing clean air, as our IoT-enabled devices provide IAQ monitoring and centralized device control to schools across the globeMolekule's education market capabilities, bolstered by the Aura acquisition, strengthen its position to leverage the nearly $500B available in U.S. Government funds for IAQ deployment in the education and public sectors PALM BEACH GARDENS, Fla., April 28, 20
PALM BEACH GARDENS, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. ("Molekule" or the "Company") (NASDAQ:MKUL), an emerging leader in air purification technology solutions, systems for healthcare and commercial smart building applications, and individual consumer protection, today reported financial results for the three months and year ended December 31, 2022 ("FY 2022"). Fourth Quarter 2022 Operational Highlights and Recent Developments The Company's Pūrgo™ air sanitization device received FDA clearance for the elimination of SARS-CoV-2, with additional testing performed to also confirm elimination of influenza and RSV.Completed the acquisition of Molekule, Inc. on Janu